Deep Health AI India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Deep Health AI India Ltd (Scrip Code: 539559) has informed BSE that a Board meeting is scheduled for May 27, 2026 at the company's registered office in Udaipur. The agenda includes consideration and approval of Audited Standalone and Consolidated Financial Results for the Financial Year ended March 31, 2026, along with the Limited Review Report. The trading window for Directors, KMPs, designated employees, and connected persons has been closed since April 1, 2026 and will remain closed until 48 hours after the results are declared, as per SEBI Insider Trading Regulations. The filing is signed by Managing Director Narayan Singh Rathore.
This is a routine prior intimation filing. The scheduled approval of FY2026 audited results on May 27, 2026 will be a key event for investors, as the trading window restriction signals that insiders are aware of the upcoming announcement.